343 related articles for article (PubMed ID: 2230113)
21. Superantigen-like properties of an antibody bispecific for MHC class II molecules and the V beta domain of the T cell antigen receptor.
Yagi J; Nakata M; Uchiyama T; Nishikawa M; Mizushima Y; Nishioka K; Ito K; Yagita H; Okumura K; Janeway CA
J Immunol; 1994 Apr; 152(8):3833-41. PubMed ID: 8144952
[TBL] [Abstract][Full Text] [Related]
22. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
23. Evidence for T cell receptor-HLA class II molecule interaction in the response to superantigenic bacterial toxins.
Fleischer B; Mittrücker HW
Eur J Immunol; 1991 May; 21(5):1331-3. PubMed ID: 2037017
[TBL] [Abstract][Full Text] [Related]
24. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
25. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
26. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
[TBL] [Abstract][Full Text] [Related]
27. Urtica dioica agglutinin. A superantigenic lectin from stinging nettle rhizome.
Galelli A; Truffa-Bachi P
J Immunol; 1993 Aug; 151(4):1821-31. PubMed ID: 8345184
[TBL] [Abstract][Full Text] [Related]
28. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
Damle NK; Klussman K; Leytze G; Linsley PS
J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
[TBL] [Abstract][Full Text] [Related]
29. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
30. T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses.
Tumang JR; Cherniack EP; Gietl DM; Cole BC; Russo C; Crow MK; Friedman SM
J Immunol; 1991 Jul; 147(2):432-8. PubMed ID: 1830062
[TBL] [Abstract][Full Text] [Related]
31. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
32. Activation of V beta 11+ murine T cells by staphylococcal enterotoxin E in the presence of accessory cells expressing MHC class II molecules.
Uchiyama T; Yan XJ; Imanishi K; Araake M; Kawachi A; Tachihara R; Shinagawa K
Jpn J Med Sci Biol; 1990 Dec; 43(6):277. PubMed ID: 2101161
[No Abstract] [Full Text] [Related]
33. Stimulation of all T cells bearing V beta 1, V beta 3, V beta 11 and V beta 12 by staphylococcal enterotoxin A.
Takimoto H; Yoshikai Y; Kishihara K; Matsuzaki G; Kuga H; Otani T; Nomoto K
Eur J Immunol; 1990 Mar; 20(3):617-21. PubMed ID: 2138560
[TBL] [Abstract][Full Text] [Related]
34. Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation.
Muraille E; De Smedt T; Thielemans K; Urbain J; Moser M; Leo O
Cell Immunol; 1995 May; 162(2):315-20. PubMed ID: 7538050
[TBL] [Abstract][Full Text] [Related]
35. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.
Nemoto E; Rikiishi H; Sugawara S; Okamoto S; Tamura K; Maruyama Y; Kumagai K
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):81-91. PubMed ID: 8880132
[TBL] [Abstract][Full Text] [Related]
36. Identification of a new type of invariant V alpha 14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen.
Yagi J; Dianzani U; Kato H; Okamoto T; Katsurada T; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T
J Immunol; 1999 Sep; 163(6):3083-91. PubMed ID: 10477573
[TBL] [Abstract][Full Text] [Related]
37. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
Owens T; Fazekas de St Groth B
J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
[TBL] [Abstract][Full Text] [Related]
38. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
39. Studies on the mechanism of stimulation of T cells by the Mycoplasma arthritidis-derived mitogen. Role of class II IE molecules.
Bekoff MC; Cole BC; Grey HM
J Immunol; 1987 Nov; 139(10):3189-94. PubMed ID: 3500207
[TBL] [Abstract][Full Text] [Related]
40. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
Wen R; Blackman MA; Woodland DL
J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
